These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9770174)

  • 1. Immune thrombocytopenia caused by piperacillin/tazobactam.
    Pérez-Vázquez A; Pastor JM; Riancho JA
    Clin Infect Dis; 1998 Sep; 27(3):650-1. PubMed ID: 9770174
    [No Abstract]   [Full Text] [Related]  

  • 2. Piperacillin/Tazobactam inducing seizures in a hemodialysed patient.
    Bassilios N; Restoux A; Vincent F; Rondeau E; Sraer JD
    Clin Nephrol; 2002 Oct; 58(4):327-8. PubMed ID: 12400853
    [No Abstract]   [Full Text] [Related]  

  • 3. Life-threatening neutropenia secondary to piperacillin/tazobactam therapy.
    Gerber L; Wing EJ
    Clin Infect Dis; 1995 Oct; 21(4):1047-8. PubMed ID: 8645807
    [No Abstract]   [Full Text] [Related]  

  • 4. Leukocytopenia, thrombocytopenia and fever related to piperacillin/tazobactam treatment--a retrospective analysis in 38 children with cystic fibrosis.
    Reichardt P; Handrick W; Linke A; Schille R; Kiess W
    Infection; 1999; 27(6):355-6. PubMed ID: 10624596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypersensitivity reaction during prolonged use of piperacillin/tazobactam in treatment of osteomyelitis.
    Behbahani R; Kostman JR
    Ann Pharmacother; 1995 Sep; 29(9):936-7. PubMed ID: 8547747
    [No Abstract]   [Full Text] [Related]  

  • 6. Piperacillin-induced thrombocytopenia reversed by high-flux hemodialysis in an uremic patient.
    Lin SY; Huang JC; Shen MC; Chuang SH; Lee MH; Chen HC
    Hemodial Int; 2012 Oct; 16 Suppl 1():S50-3. PubMed ID: 23036037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piperacillin/tazobactam therapy for diabetic foot infection.
    Zeillemaker AM; Veldkamp KE; van Kraaij MG; Hoekstra JB; Hoynck van Papendrecht AA; Diepersloot RJ
    Foot Ankle Int; 1998 Mar; 19(3):169-72. PubMed ID: 9542990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid-onset piperacillin-tazobactam induced thrombocytopenia.
    Shaik S; Kazi HA; Ender PT
    J Pharm Pract; 2015 Apr; 28(2):204-6. PubMed ID: 25609660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piperacillin/tazobactam-induced immune-mediated thrombocytopenia in the intensive care unit.
    Boyce K; Brar H; Stabler SN
    J Clin Pharm Ther; 2016 Dec; 41(6):730-732. PubMed ID: 27670947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections.
    Siami G; Christou N; Eiseman I; Tack KJ;
    Antimicrob Agents Chemother; 2001 Feb; 45(2):525-31. PubMed ID: 11158750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid onset severe thrombocytopenia following reexposure to piperacillin-tazobactam: report of two cases and review of the literature.
    Alzahrani M; Alrumaih I; Alhamad F; Abdel Warith A
    Platelets; 2018 Sep; 29(6):628-631. PubMed ID: 29863943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piperacillin/tazobactam: a critical review of the evolving clinical literature.
    Sanders WE; Sanders CC
    Clin Infect Dis; 1996 Jan; 22(1):107-23. PubMed ID: 8824974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid-Onset Thrombocytopenia Following Piperacillin-Tazobactam Reexposure.
    Nguyen VD; Tourigny JF; Roy R; Brouillette D
    Pharmacotherapy; 2015 Dec; 35(12):e326-30. PubMed ID: 26684560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Faecal concentrations of piperacillin and tazobactam in elderly patients.
    Wilcox MH; Brown A; Freeman J
    J Antimicrob Chemother; 2001 Jul; 48(1):155-6. PubMed ID: 11418534
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug fever due to piperacillin/tazobactam loaded into bone cement.
    Park HB; Choi JS; Park SH; Kee WJ; Koh YI
    J Korean Med Sci; 2011 Feb; 26(2):301-3. PubMed ID: 21286026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piperacillin/tazobactam induced thrombocytopaenia--a delayed response.
    Macwilliam JL; Mistry R; Floyd MS; Baird AD
    BMJ Case Rep; 2012 Jul; 2012():. PubMed ID: 22778457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe bone marrow suppression and hepatic dysfunction caused by piperacillin/tazobactam.
    He ZF; Wu XA; Wang YP
    Scand J Infect Dis; 2013 Nov; 45(11):885-7. PubMed ID: 23826789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is high-dose β-lactam therapy associated with excessive drug toxicity in critically ill patients?
    McDonald C; Cotta MO; Little PJ; McWhinney B; Ungerer JP; Lipman J; Roberts JA
    Minerva Anestesiol; 2016 Sep; 82(9):957-65. PubMed ID: 27054905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piperacillin-tazobactam versus ciprofloxacin plus amoxicillin in the treatment of infective episodes after liver transplantation.
    Philpott-Howard J; Burroughs A; Fisher N; Hastings M; Kibbler C; Mutimer D; Patch D; Rolando N; Wade J; Wendon J; O'Grady J
    J Antimicrob Chemother; 2003 Dec; 52(6):993-1000. PubMed ID: 14585863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible role of cellular immunity: a case of cellulitis.
    Baddour LM; Googe PB; Prince TL
    Clin Infect Dis; 2001 Jan; 32(1):E17-21. PubMed ID: 11106315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.